When you think about it, there are very few modern medicines with the following characteristics:
1. They are not antibiotic and do not therefore have the risk of side effects and increasing resistance,
2. They treat a particularly common disease,
3. They can be purchased over the counter at any pharmacy,
4. They cost less than a visit to a GP (unless one is bulk billed),
5. They are unique, as in nobody has a competing product which is proven to work.
This is going to go off like a rocket!
The only thing I am predicting is that the wholesalers and Aspen have not ordered sufficient stock and there will be shortage.
- Forums
- ASX - By Stock
- SPL
- Ann: First VivaGel BV launch globally in Australia by Aspen
Ann: First VivaGel BV launch globally in Australia by Aspen, page-4
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $1.106K | 10.53K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 73581 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 70058 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73431 | 0.105 |
3 | 198569 | 0.100 |
2 | 110111 | 0.099 |
3 | 483557 | 0.096 |
1 | 824859 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 70058 | 2 |
0.115 | 202695 | 5 |
0.120 | 251197 | 7 |
0.125 | 30000 | 1 |
0.130 | 138570 | 2 |
Last trade - 11.11am 18/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online